• Laurent DECORY

China Oncology: an increasing burden and growth opportunity

With 50 % of global gastric, hepatic, and esophageal cancer cases and high lung cancer incidence, China Oncology market is a unique and challenging opportunity for multinational and local Biopharma.


BlueJet Consulting can help portfolio, launch and go-to-market strategy.


#commercialexcellence

#oncology


Continue reading